foxo4-dri senolytic human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound Tools to eliminate senescent cells
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29






























